PHARMACITY
ActiveSummary
PHARMACITY is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show negative equity (-€296,494) and a net result of -€47,304. Equity is shrinking by about 50% per year across the filed financial years. Its solvency ranks better than 7% of 77 sector peers (NACE 65, financial year 2025). The company has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals.
History
Acts, filings and financial milestones
23-02
Gazette deed
Resignations: Pierre Massar, Laurent Lacroix and Jean-Antoine LacroixAppointments: Pierre Massar, Laurent Lacroix and Jean-Antoine Lacroix · Capital conversion · Reserve release17 facts ▸
- General meeting, 13-12-2023
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Reserve release, “suppression du compte de capitaux propres statutairement indisponible, formes et majorités de la modification des statuts” (deed in French)
- Amendment of the articles
- Capital
- Director resignation, Pierre Massar (manager)
- Director resignation, Laurent Lacroix (manager)
- Director resignation, Jean-Antoine Lacroix (manager)
- Director appointment, Pierre Massar (director (not named in the articles))
- Director appointment, Laurent Lacroix (director (not named in the articles))
- Director appointment, Jean-Antoine Lacroix (director (not named in the articles))
- Director discharge, Pierre Massar
- +5 further facts in this act
About the unread acts
Of the 7 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 6 have not been read yet: what they contain is neither established nor disproved here.